Chiromics LLC is a drug discovery company that designs and synthesizes broadly diverse chemical compound libraries, using a patented �cascade catalysis� technology that produces drug-like molecules with a stereochemically defined framework. The novel structures and accessible complexity of these compounds expands the access to important disease targets and accelerates the hit-to-lead time for identification of novel drugs. Formed in 2009 and based in Princeton, New Jersey, Chiromics has established collaborations with leading biotech and pharmaceutical companies for licensing and screening of its libraries against a broad array of disease targets.

Leveraging organocatalysis to generate business opportunities: Chiromics, LLC unlocks value in novel chemical space

248th National Meeting (2014)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.